Azathioprine and mercaptopurine, two of the most widely used medicines for Crohn's disease and ulcerative colitis (UC), can in rare cases cause a liver condition in pregnancy called intrahepatic cholestasis of pregnancy (ICP). The Medicines and Healthcare products Regulatory Agency (MHRA), which regulates medicines in the UK, issued a warning about it in May 2025. If you are pregnant, or planning a pregnancy, and take one of these medicines, it is worth knowing the signs.
What is ICP?
ICP is a liver condition that develops during pregnancy. "Cholestasis" means that the flow of bile, a fluid made by the liver, slows down, so substances called bile acids build up in the blood. The main symptom is intense itching without a rash.
ICP matters because it raises the risk of the baby being born early (preterm birth) and, when bile acid levels are very high, of stillbirth. Spotting it early means you can be monitored closely. Ordinary ICP, not linked to any medicine, affects about 1 in 150 pregnancies.
Which medicines are affected?
Azathioprine, mercaptopurine and tioguanine (also spelled thioguanine) belong to a group of medicines called thiopurines. ICP has been reported with azathioprine and mercaptopurine, and because all three are handled by the body in the same way, the MHRA believes the risk applies to the whole group.
How rare is it?
The warning is based on a small number of case reports in medical journals, mostly in women being treated for inflammatory bowel disease (IBD) or after an organ transplant. The MHRA has not given a figure for how often it happens, but says it is thought to be much less common than ordinary ICP.
Some of the reported cases were serious, and some ended in the loss of the baby. The MHRA points out that serious cases are more likely to be reported, so the reports may make the problem look worse than it usually is.
ICP linked to these medicines can behave differently from the ordinary kind:
- It may start earlier in pregnancy.
- It may not improve with ursodeoxycholic acid, the medicine usually used to treat ICP.
- Liver tests may improve if the thiopurine is stopped or the dose is lowered.
Signs to look out for
Contact your doctor or midwife straight away if you are pregnant and notice:
- Intense itching without a rash, often on the palms of the hands and soles of the feet
- Feeling sick (nausea)
- Loss of appetite
What it means for you
Don't stop your medicine unless your doctor or midwife tells you to. For most women with IBD, staying on azathioprine or mercaptopurine during pregnancy is the safest choice, because a flare-up is a greater risk to both mother and baby. Specialists decide on treatment in pregnancy by weighing up the benefits and risks for each woman.
It helps to make sure your midwife and maternity team know that you take a thiopurine, so they can watch for ICP. If ICP is diagnosed, your doctors will decide what to do case by case, sometimes with a liver specialist (hepatologist). They will usually check the level of bile acids in your blood, as higher levels mean a higher risk of an early birth and need closer monitoring.
If you are planning a pregnancy and take one of these medicines, talk to your IBD team about it beforehand. You can report any suspected side effect through the MHRA's Yellow Card scheme.
For more about the medicine, see Azathioprine, and for planning a pregnancy with IBD, see Pregnancy and Inflammatory Bowel Disease.
Ref: Medicines and Healthcare products Regulatory Agency. Thiopurines and intrahepatic cholestasis of pregnancy. Drug Safety Update, volume 18, issue 10, May 2025.